- Strong Q4 2025 Performance Revenue grew 9%, adjusted EBITDA net of NCI rose 10%, and adjusted EPS increased 20% compared to Q4 2024.
- 2026 Revenue Guidance Expected $18.4–$18.8 billion revenue range (6–8% growth) and $2.64–$2.79 billion adjusted EBITDA (2–8% growth).
- Capital Expenditures & Expansion 2026 capex of $950M–$1.1B supports new acute care hospitals, outpatient behavioral locations, and facility upgrades.
- AI & Operational Efficiency AI deployment reduces administrative costs (e.g., post-discharge calls) and targets 4–6% revenue growth via pricing and volume.
- Medicaid & Regulatory Risks Florida Medicaid program approval pending, while California faces hurdles; new California staffing rules project $35M annual headwinds.
Operational Highlights
In 2025, UHS opened two new acute care hospitals and laid the groundwork for significant new acute care capacity to come online during 2026. The company also accelerated its outpatient behavioral strategy, operating 119 outpatient behavioral locations. The outpatient behavioral business is growing, with 120 outpatient locations offering step-down and step-in services, and plans to open at least 10 new "1,000 branches wellness" locations in 2026.
Guidance and Outlook
UHS expects 2026 revenue to range between $18.4 billion and $18.8 billion, representing growth of 6% to 8%. Adjusted EBITDA net of NCI is expected to range between $2.64 billion and $2.79 billion, representing growth of 2% to 8%. The guidance assumes same-facility volume growth of 2% to 3% for both segments in 2026. Analysts estimate next year's revenue growth at 4.5%, slightly below the company's guidance.
Valuation and Metrics
UHS's current valuation metrics, including a P/E Ratio of 8.8, P/B Ratio of 1.8, and EV/EBITDA of 6.61, indicate a relatively attractive valuation. The company's ROE of 21.03% and ROIC of 11.66% demonstrate strong profitability. With a Net Debt / EBITDA ratio of 1.83, UHS's leverage is at the low end of its target range, providing flexibility for potential M&A opportunities or share repurchases.
Technological Investments and Efficiency
The company is investing in AI technology, including a partnership with Hippocratic AI, to improve efficiency and reduce costs. Examples include streamlined revenue cycle management and decreased expenses for post-discharge calls. UHS expects these efforts to drive efficiency and improve financial performance over time.
Behavioral Business and Pricing
In the Behavioral business, pricing normalization and hiring efforts have led to sequential improvement in patient volume growth in 2025. The company expects to achieve a 2% to 3% target growth range in 2026, driven by investments in staff and headcount. UHS expects pricing in its Behavioral business to normalize in 2026 after significant gains in 2025, driven by the benefit of DPPs.